Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hier

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Head & Neck|March 11, 2026
Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of LifeHaley Deamond, Cyril Devault-Tousignant, Jacob Lang, et al.
Pilot and Feasibility Studies|December 21, 2024
PTSD Coach as an early mobile intervention to improve cancer-related anxiety and psychosocial oncology uptake in patients newly diagnosed with head and neck cancer: pilot randomized controlled trialLaurence Ducharme, Chris Lo, Michael Hier, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal StudyJustine G Albert, Christopher Lo, Zeev Rosberger, et al.
Journal of Affective Disorders|March 22, 2023
Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal studyMelissa Henry, Raphaële Harvey, Lawrence M Chen, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 27, 2025
Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity CancerGabriel S Dayan, Houda Bahig, Justine Colivas, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 9, 2023
Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity CancerGabriel S Dayan, Houda Bahig, Stephanie Johnson-Obaseki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
The Lancet. Oncology|August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2025
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trialDavid A Palma, Eitan Prisman, Eric Berthelet, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Head & Neck|March 11, 2026
Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of LifeHaley Deamond, Cyril Devault-Tousignant, Jacob Lang, et al.
Pilot and Feasibility Studies|December 21, 2024
PTSD Coach as an early mobile intervention to improve cancer-related anxiety and psychosocial oncology uptake in patients newly diagnosed with head and neck cancer: pilot randomized controlled trialLaurence Ducharme, Chris Lo, Michael Hier, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal StudyJustine G Albert, Christopher Lo, Zeev Rosberger, et al.
Journal of Affective Disorders|March 22, 2023
Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal studyMelissa Henry, Raphaële Harvey, Lawrence M Chen, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 27, 2025
Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity CancerGabriel S Dayan, Houda Bahig, Justine Colivas, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 9, 2023
Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity CancerGabriel S Dayan, Houda Bahig, Stephanie Johnson-Obaseki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
The Lancet. Oncology|August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2025
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trialDavid A Palma, Eitan Prisman, Eric Berthelet, et al.
Pageof 9